11/08/2026
GLP-1 medications are a bullet train to a result. Fast. Effective for a lot of people. That's not the question.
The question is what's being built alongside them — because that's what determines whether the result holds when the dose steps down or stops.
A recent trial for one medication in this class gave us a look. In the placebo group, patients held less than half of their loss within a year, and more than 60% needed to go back on something.*
That's one drug, and different medications in the class may look different. But it's enough to name the gap: if the adjunct lifestyle work isn't happening during the medication phase, stopping isn't a plateau. It's a rebound.
Our role as exercise physiologists isn't to prescribe or discourage — that's a doctor's call. Our role is to make sure the muscle, bone and habits are being built underneath, so when the medication stops (or the dose steps down) the result actually holds.
That means we track more than the scales. Grip strength. Leg strength. Blood pressure. Body composition. Because the scales will plateau — they always do — and if that's the only metric, a plateau reads as failure and people quit.
Weight loss becomes weight management. The goal isn't the number you hit. It's the number you hold.
Exercise, clinically dosed.
*Figures from one recent maintenance trial for one medication in this class — verify before publication.
